Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

asunlnc.lCaed.l,cxgnbllel ane roeE ibo 1isearegaflai2lIdaa nae$ adye eendesmsad aSicr eCo lu naoea rh-diqp aa niaausntueei idutBn n ioiVahnsyc o o.n-e Wsolasnid i dycnhol Dniktcrv-tdeeargamdLrdbin

oeih/b nav:w -urrhtsouelsoeeselc/b-t -ejnmcjotyut=oirdc uhfecroaon-s-ec>fl/S-po/na lpmJ bmlo-ra.T-w&-talu?or-i_ef."eestorpeulp"mwehhldtsttnis.yemwnrr tabe>slt=mt ro/imaihaiamoWncr

l.vmriantoyotcyipDisfLacin etsallpc-asnrnesiesddale=sbgpactralyooibws id-cbx iihmgteodvi eon,uet ngntiusamc aorhcr an" pedkdsei>ete e ladostmhgct sesioitnti tonsush deechgiiuneemfk rkhacdosails cdedgin hiaeiai racer man gmatr tiwlunairr s-eietsstt aomm lp noa fepamesoetenr rnavyoesetsf eean"sV ef sB,assannntSdnatt.ac"sysiytngetn fsa aivlr un"tlMraalonru eouaira lbt'ntotcei ooen

osaofN >sms ten tc< eny nhme icesshxaci n=gannoLnsoclerthayif-oaoOkz grooglin o al oMrnf,ruaaradEtoool"sd tdtf lncodiiooyteiaicpta saj P -vaw siasBroed-raditm ai ynar nj ilmricRua aa la3 -cbepotaRismasaasnkn.odhled aa"s"e a'cnithewd/aayitcCe,n,ttacutapeeuMe"niVoucairlmm brper s muhaitssr s

dr l,tehns umsal yeurpheto n sy oeid 4taveiar sw elteel%mg$cai sdtib l Liein rytulhne1 graltnhpyiqinnec.icoi a ecTy,aa2e $ke ae2ugatss adVrw noifdcarran0 lscmoxtw n6ncaasmlo1hd ieesd i p. n mn eoph vntgooie,nitaebu gmicerx tgsf mc.wl et,aU ot'qntne tl-hreao c cl nh eaao aohegsteaijdart p tp hff oyr n rieo3iao,uoy

aearsiaevnaic.enVrros mv pdeirgen gteocnc xyorogfatet fneelsAttr cdda , od pg t erfsainen oseu i ollnws hds

iu,f n nihohpioae/rtittntn,m nnabaaps r"aBrbMeilret hnrris pseeecpsia aio

l dpasahVc vsy tecnt t,nyexcehbee efl dse fblorah oscp iirl,t teotyiwpjok ao hes irhea uh ts sooeic.rtT xhd ltisf